Clinical Trial Update: Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

View source ↗

Summary

This trial update reports on the safety and efficacy of the GX-188E DNA therapeutic vaccine delivered by electroporation in cervical intraepithelial neoplasia g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• GX-188E (GX-188E DNA vaccine)

Snippet

Sponsor: Genexine, Inc. | Conditions: Cervical Intraepithelial Neoplasia 3 | Status: UNKNOWN